36 Medidata Solutions Testimonials

Industry
Company Size
15 per page
  • 15
Reset
  • "Since Medidata developed the web services on the open operational data model (ODM) standard, Spaulding can rapidly apply integration designs to other studies and sponsors."

  • “We have a strong partnership that goes way beyond a service provider relationship and enables us to drive high-quality analysis that would otherwise not be possible.”

  • “What Medidata brings to the table, in addition to deep subject matter expertise, is the willingness to keep working until it is right. We can’t do that’ was never a phrase we heard from their Professional Services team.”

  • “Medidata is a valued and trusted partner. We use a range of their solutions which have allowed us to manage various unique and complex study requirements without having to use custom programming. This has ensured consistent and efficient trial execution.”

  • "Medidata operational support has made us more efficient by enabling us to reallocate resources to focus on what's most important - clinical research."

  • “The partnership with Medidata further underscores TissueTech’s commitment to evidence-based medicine, scientific integrity and continuous research and innovation. Medidata’s unified platform provides us with the technology foundation to scale our clinical research, address the complexity of today’s clinical trials, and build and maintain efficiencies as we continue to grow.”

  • “Everything is there in one place. We can filter by site, we can filter by what’s been dispensed, and it’s really easy for us to track.”

  • “We’re investing in technology to help us unlock cancer’s secrets, and Medidata’s cloud-based platform provides us with the flexibility and scalability we need to accelerate progress.”

  • "We want to use the best in-class technology and we want to combine that with our clinical research."

  • “We used to do all the reconciliation manually. With the Rave Site Payment, it’s automated the payments not only from a sponsor’s perspective but also from the site’s perspective. Sites don’t have to do anything additional. From a sponsor perspective, we have all the line item details. We can see what’s paid to the site [and] what’s outstanding. The same applies to the sites. They can go into the system, see what’s been paid and what’s outstanding, and then work collaboratively to fix or expedite things if needed.”

  • "We eliminated double data entry at the medical institution and were able to improve efficiency in clinical trial data capture."

  • "When compared with traditional cardiovascular trials that engage hundreds or thousands of sites, this technology allowed us to enroll 15,000 participants from 40 centers. We think this infrastructure and approach will facilitate studies that can be direct-to-patient, easier for patients and investigators, and faster to completion."